Episode 31 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 2: Diagnostic Factors and Specialty Lab Monitoring

Patients with interferon gamma (IFN-γ)-driven diseases such as hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) face significant diagnostic and therapeutic challenges, with delays in diagnosis and limited effective treatments often resulting in poor outcomes. Despite advances in understanding the role of IFN-γ in these conditions, there remains an unmet need for more precise diagnostic tools and faster, targeted therapies to manage the hyperinflammatory states that characterize these diseases.

Launch Date: November 25, 2024

Release Date: November 25 2024

Expiration Date: October 31, 2025

FACULTY

Scott Canna, MD

Assistant Professor of Pediatrics

Childrens Hospital of Philadelphia

Pui Lee, MD

Assistant Professor of Pediatrics

Boston Childrens Hospital

Ashish Kumar, MD, PhD

Professor of Pediatrics

Cincinnati Children’s Hospital Medical Center

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/conversations-in-ifn-y-driven-diseases-decoding-the-gamma-signal-1